Conference Call Details Date: Jul 28, 2020 View more earnings on AMGN Time: 05:00 PM ET Webcast URL: https://edge.media-server.com/mmc/p/zu6j6vvu Technicals 52-week high: $264.97 52-week low: $173.12 Price action over last quarter: Up 12.56% Company Description Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products.Amgen's acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Nexavar and Kyprolis.